ProjectUpdated on 6 August 2026
多肽(多肽原料药/中间体/CDMO)项目
About
创新药定制合作方面,我司重点打造“全球百亿销量-降糖、减重药王”的多肽类药物工厂“交钥匙”服务平台,集聚“设备-工艺-体系”三维融合优势,提供端到端的多肽原料药CDMO解决方案,从分子结构到上市许可,全链掌控,加速转化,让多肽药物开发像“拼乐高”一样简单可靠。目前拉美、中东、中亚、东南亚等地均在积极对接中,相信将成为科技出海,全球共赢的新增长点,目前我司已经在中亚某国相关部委和国药企业达成初步合作协议,计划在哈过生产生产仿制药司美格鲁肽及部分小核酸。该项目实施过程中还需要部分资金。
Project Location
- Mexico
Project Format
- Public-Private Partnership Project
ESG (Environmental, Social, and Governance)
- No
Project Stage
- Feasibility Study Completed
Main Project Sector
- Technology
Technology
- Medical Technology
Urban Development
- Health Facilities
Total Project Value
- 50,000,001 USD or above
Investment Capital Required
- 10,000,001 to 25,000,000 USD
Interested Format of Cooperation
- Open for Negotiation
- Public–private partnership / Concession
Preferred Financing Model
- Open for negotiation
Previous Funding Stage
- None
Main Service(s) Required
- Financial Services
Organisation
Shanghai, China
Similar opportunities
Project
- No
- None
- Private Project
- Food Processing
- Project Planning
- Financial Services
- Professional Services
- Agriculture, Food and Rural Development
LIN JIN
商务部副总监 at 寿仙谷药业
杭州, China
Service
- Professional Services
志平 刘
产品开发总监,主任级高级研究员,董事长特别代理 at 中国标准药物集团有限公司
广东, China
Project
- Yes
- None
- Private Project
- Project Planning
- Urban Development
- Property Technology
- Professional Services
- 50,000,001 USD or above
- 50,000,001 USD or above
- Transportation Services
- Warehouse And Logistics Parks
- Transport and Logistics Infrastructure
王 清杰
董事长 at 陕西华泰阳光科工贸集团有限公司
西安市, China